Each outcome's chance over time on Polymarket. The dots along the bottom are headlines about its subject: point at one to read it.
Every outcome
Outcome
Chance
Day
Bid
Ask
Pays
Traded
✓ Warner Bros. Discovery
>99%
▲ 5
100¢
100¢
$6.1K
✓ iRobot
>99%
▲ 73
100¢
100¢
$3.3K
✓ Pizza Hut
>99%
▲ 4
100¢
100¢
$613K
✓ Caesars Entertainment
>99%
▲ 43
100¢
100¢
$62.4K
✓ Cursor
>99%
▲ 12
100¢
100¢
$69.2K
Perplexity AI
14%
13¢
15¢
$6.67
$2.4M
PayPal
14%
▲ 1
13¢
14¢
$7.14
$127K
Viking Therapeutics
12%
11¢
13¢
$7.69
$1.7M
Brown-Forman
8%
7¢
8¢
$12.50
$8.5K
GitLab
6%
▲ 1
6¢
7¢
$14.29
$1.2M
Zoom Video Communications
6%
6¢
6¢
$15.63
$432K
MGM Resorts
5%
▼ 2
5¢
6¢
$16.67
$64K
Lovable
5%
5¢
5¢
$19.61
$996K
Snapchat
4%
4¢
4¢
$22.73
$152K
BP
4%
3¢
4¢
$25.64
$1.1M
Nebius Group
3%
3¢
3¢
$33.33
$8M
Ubisoft
2%
2¢
2¢
$52.63
$635K
OpenAI
2%
2¢
2¢
$55.56
$677K
Anthropic
1%
1¢
2¢
$62.50
$198K
"Pays" is what a $1 stake returns if that outcome happens, at the price shown (before any fees). Bid and ask are the best prices to sell and buy "Yes".
Why Viking Therapeutics’ Oral Obesity Strategy Will Be a Make-or-Break Focus on Oct. 2824/7 Wall St. · 25 h agoViking Therapeutics (NASDAQ:VKTX | VKTX Price Prediction) reports third-quarter results on October 28, 2026. Shares fell 41.42% over the past month, so management has to make the case for its newly launched oral VK2735 Phase 3 program on…
Transcript : Viking Therapeutics, Inc. - Special CallMarketScreener · 3 days agoPresentation Operator MessageOperator Welcome to the Viking Therapeutics VK2735 Maintenance Study Top Line Data Conference Call. [Operator Instructions] As a reminder, this conference call is being... Transcript : Viking Therapeutics, Inc…
Viking Therapeutics, Inc.: Relative Strength Chart - Stock NasdaqMarketScreener · 3 days agoCompare Viking Therapeutics, Inc. with the company of your choice via a Relative Strength chart. Real-time VKTX price, Nasdaq stock exchange Relative Strength Chart Viking Therapeutics, Inc. Biotechnology & Medical Research All financial…
UBS Initiates Viking Therapeutics at Buy With $94 Price TargetMarketScreener · 3 days agoViking Therapeutics has an average rating of buy and mean price target of $95.47, according to analysts polled by FactSet. ... Biotechnology & Medical Research UBS Initiates Viking Therapeutics at Buy With $94 Price Target Published on…
Viking Therapeutics Initiates Trial of VK2735 Maintenance Dosing Regimens in ObesityMarketScreener · 3 days agoViking Therapeutics said Tuesday it has begun a clinical trial to explore oral and additional subcutaneous VK2735 dosing regimens to maintain initial weight loss in patients with obesity. The... Biotechnology & Medical Research Viking…
Viking Therapeutics Starts Phase 3 Program for Oral VK2735 in Adults With ObesityMarketScreener · 3 days agoViking Therapeutics said Wednesday it has started the phase 3 clinical program for the oral formulation of its investigational GLP-1 product VK2735 in adults with obesity. The program includes two... Biotechnology & Medical Research Viking…
Perplexity AI Predicts an Explosive Q4 for Uniswap: Should UNI Holders Be Excited?icobench.com · 4 days agoHome » News » Perplexity AI Predicts an Explosive Q4 for Uniswap: Should UNI Holders Be Excited? Silicon Valley-based Perplexity AI predicts a wildly bullish move for Uniswap (UNI) by early 2027, citing a hypothetical scenario as the…
Odds are traders' prices on Kalshi, Polymarket, ForecastEx and Crypto.com, not forecasts by 4Search. Prices read from the venues 4 min ago. Prices may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts. Not betting or investment advice.
Prediction-market prices are what traders pay for each outcome on Kalshi, Polymarket, ForecastEx and Crypto.com, read as the market's implied chance. They are not forecasts by 4Search, can move fast and can be wrong; they are read every few minutes and may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts at their price. News comes from the 4Search index; prices of stocks, rates and coins from 4Search Finance. Nothing here is betting, financial or investment advice. Terms of use. How to use Predictions